Jon Kleu - CEO

---

Mr. Kleu has devoted his entire career to building commercial teams and developing strategies for various companies within the pharmaceutical industry. Prior to SNP Therapeutics, Mr. Kleu began his career with the Upjohn Company (Pfizer) where he worked in various commercial leadership roles before joining Daiichi Sankyo as an inaugural member of the management team charged with building its’ first U.S. commercial presence. Mr. Kleu served as Vice President of Sales for Daiichi Sankyo, (a global pharmaceutical company; top 20 worldwide). Mr. Kleu was a member of the executive management team that built the US Commercial division to over 3,000 employees and $3B in annual US revenue through the launch of 6 successful brands in 15 years. Over the past 5 years Mr. Kleu has worked as a Vice President for the commercial division of SyneosHealth (Nasdaq:SYNH), a fully integrated biopharmaceutical solutions provider, specializing in Contract Research  and Contract Commercial solutions for the pharma sector). He has partnered with a number of major companies to build and execute commercial strategies for many successful brands (i.e., J&J, Pfizer, Eli Lilly, and Forest Labs). While at Syneos Health Mr. Kleu has also been successful in building commercial strategies for new start-up companies by providing a variety of services from his teams to clients, (i.e., consulting, marketing, operations, compliance, legal, compensation, medical, payer reimbursement, recruiting, and training). Mr. Kleu is a graduate of The University of North Carolina at Greensboro with a major in Business Administration and a concentration in Marketing. Jon and his family reside in the Raleigh, North Carolina area.